New Cancer Tests Let Thousands Skip Chemotherapy Safely
A breakthrough genomic test allowed two-thirds of breast cancer patients to safely skip chemotherapy while maintaining the same survival rates. Medical innovations presented at this year's ASCO meeting could transform how doctors treat multiple cancer types.